← Back to Search

LungTalk for Increasing Lung Cancer Screening

Phase < 1
Waitlist Available
Led By Lisa Carter-Harris, PhD, NP, RN
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
LDCT screening-eligible women who received a BiRADS 1 (negative) or 2 (benign/non-cancerous finding) result from a screening mammogram in the last 7 days
Women who currently smoke or quit within past 15 years as per self report
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will develop a way to increase awareness of lung cancer screening among eligible women, by email and an internet-based health communication tool.

Who is the study for?
This trial is for women aged 50-80 who have a history of heavy smoking (at least 20-pack-years), either currently smoke or quit within the last 15 years, and haven't had lung cancer screening before. They must have recently had a mammogram with no signs of breast cancer.Check my eligibility
What is being tested?
The study is testing 'LungTalk', a digital tool designed to raise awareness about lung cancer screening through emails and an interactive web-based platform featuring text, audio, video, and animations.See study design
What are the potential side effects?
Since this trial involves educational material rather than medical treatment, there are no direct physical side effects. However, participants may experience increased anxiety or concern regarding their health due to information received.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My recent mammogram was negative or showed benign findings.
Select...
I am a woman who has smoked in the last 15 years.
Select...
I am between 50 and 80 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants accrued through digital outreach to identify breast screening participants eligible for lung screening

Trial Design

1Treatment groups
Experimental Treatment
Group I: Women who have had a mammogramExperimental Treatment1 Intervention
Participants will consist of eligible women who have had a mammogram

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,928 Previous Clinical Trials
591,778 Total Patients Enrolled
1 Trials studying Smoking
Lisa Carter-Harris, PhD, NP, RNPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
Tali Amir, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

Media Library

LungTalk Clinical Trial Eligibility Overview. Trial Name: NCT04848961 — Phase < 1
Smoking Research Study Groups: Women who have had a mammogram
Smoking Clinical Trial 2023: LungTalk Highlights & Side Effects. Trial Name: NCT04848961 — Phase < 1
LungTalk 2023 Treatment Timeline for Medical Study. Trial Name: NCT04848961 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many medical settings are currently hosting this scientific experiment?

"Currently, this clinical trial is being conducted in 11 distinct sites. These include Middletown, Harrison and Montvale as well as other cities across the country. To minimize transportation demands, it would be prudent to select a medical centre close by when enrolling into this study."

Answered by AI

Is this experimental protocol currently open to recruitment?

"According to the clinicaltrials.gov website, this experiment is still enrolling volunteers. It was initially posted on April 9th 2021 and most recently updated on September 30th 2022."

Answered by AI

Does this scientific trial extend to participants in their seventies?

"The age requirement for this particular clinical trial is between 50 and 80 years old. For those younger than 18, there are 40 separate trials available, while 1539 studies exist for individuals aged 65 or more."

Answered by AI

What is the current enrolment rate for this trial's participants?

"To meet the study's goals, 150 eligible subjects are necessary. Participants can join this trial at either Memoral Sloan Kettering Monmouth (Limited Protocol Activities) in Middletown, New york or Memoral Sloan Kettering Westchester (Limited Protocol Activities) in Harrison, Connecticut."

Answered by AI

Is my eligibility applicable for participation in this clinical research?

"This clinical trial seeks 150 candidates aged between 50 and 80 that have a smoking history of 20 pack years. Qualified applicants must possess the following attributes: negative or benign BiRADS 1 result from mammogram within last 7 days, age range of 50 to 80 years old, self-reported ≥20-pack year combustible cigarette usage, currently smokes or quit within past 15 years as per self report, never participated in lung screening according to own admission."

Answered by AI
~0 spots leftby Apr 2024